UltraSound-Guided Versus Non-Ultrasound-Guided Botulinum Toxin Injections in Cervical Dystonia [CUSTODY]
A legfontosabb adatok
- Ki végzi
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Hol
- Milan (Olaszország)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 100 fő, tervezett
- Kezdés
- 2025. nov. 1.
- Várható befejezés
- 2027. dec.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Ultrasound-guided botulinum toxin injection
- Non-ultrasound-guided botulinum toxin injection
- A regiszteradat frissítve
- 2026. február 13.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with idiopathic cervical dystonia (neck muscle spasms with no known cause) who already get botulinum toxin type A injections and respond well to them.
- Életkor
- 18 years and older
- Nem
- All sexes
- A betegség stádiuma
- Clinical diagnosis of idiopathic cervical dystonia. Inherited or acquired types cannot join.
- Korábbi kezelés
- Must have had botulinum toxin type A (BoNT) treatment for cervical dystonia before, with a good response, on a stable dose and schedule. At least 4 months must have passed since the last BoNT injection at screening. Other dystonia medicines (for example anticholinergics, benzodiazepines), if any, must be at a stable dose for at least 3 months before screening.
A részvétel fő kizáró okai
- Diseases where botulinum toxin cannot be used, such as myasthenia gravis
- Allergy to Botulinum-A Toxin
- Pregnant or breastfeeding, planning pregnancy, or no safe birth control
- Other serious unstable illness, such as kidney failure, liver problems or heart disease
- In another study with an investigational drug within the 30 days before or during this study
A regiszter feltételei, szó szerint
Mind a 9 feltétel megnézéseKevesebb
Ki vehet részt
- Minimum age 18 years old
- Clinical diagnosis of Idiopathic Cervical Dystonia
- On a stable dose of other medications (if any) used for focal dystonia treatment (e.g. anticholinergics and benzodiazepines) for at least 3 months prior to screening and expected to be maintained throughout the study
- Treatment non-naïve to BoNT type A therapy for CD
- At least 4 months have passed between the last BoNT injection at screening
- Good clinical response to previous BoNT injections, on stable dosing and treatment scheme
- Informed Consent as documented by signature
- Ability to perform study requirements (to attend assessment and treatments)
Ki nem vehet részt
- Diagnosis of other types of Cervical Dystonia (Inherited and Acquired); Concomitant diagnosis of diseases that contraindicate the use of botulinum toxin, such as myasthenia gravis; Known hypersensitivity or allergy to Botulinum-A Toxin; Women who are pregnant or breast feeding; Intention to become pregnant during the study; Lack of safe contraception; Other clinically significant and unstable concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.); Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc. of the participant; Participation in another study with investigational drug within the 30 days preceding and during the present study; Previous enrolment into the current study
Helyszínek itt: Olaszország
- Fondazione IRCCS Istituto Neurologico Carlo BestaMilan, OlaszországContact: Valentina Leta, MDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Cervical dystonia is a condition that causes the neck muscles to tighten or spasm, leading to abnormal head positions and pain.
A teljes eredeti leírásKevesebb
The main questions it aims to answer are:
* Do ultrasound-guided BoNT injections improve quality of life more than injections without ultrasound? * Are ultrasound-guided injections as safe as injections without ultrasound?
Researchers will compare:
* BoNT injections with ultrasound guidance * BoNT injections without ultrasound guidance (based only on body landmarks)
Participants will:
* Receive both types of injections during the study (one first, then the other) * Complete questionnaires about quality of life, movement, pain, and mood * Attend follow-up visits over about 8 months About 37 adults with cervical dystonia will take part. The study will take place at the Fondazione IRCCS Istituto Neurologico Carlo Besta in Milan, Italy.
A vizsgálat 2 csoportja
- Ultrasound-Guided BoNT InjectionsA vizsgált kezelés
Participants receive botulinum toxin type A injections into cervical muscles using real-time ultrasound guidance to visualise target muscles and surrounding structures
Kezelés: Ultrasound-guided botulinum toxin injection és Non-ultrasound-guided botulinum toxin injection
- Non-Ultrasound-Guided BoNT InjectionsSzínlelt kezelés, összehasonlításként
Participants receive botulinum toxin type A injections into cervical muscles using anatomical landmarks, without ultrasound guidance. The ultrasound device is present but the screen is turned off to maintain blinding.
Kezelés: Ultrasound-guided botulinum toxin injection és Non-ultrasound-guided botulinum toxin injection
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Randomised, Cross-over, Double-blind, Sham-Controlled Superiority Trial of UltraSound-Guided Versus Non-Ultrasound-Guided Botulinum TOxin Injections in Cervical DYstonia
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. február 13.